Abstract
PROMIS® Physical Function and Fatigue PROs show good correspondence with steps/hour making them easy, useful tools for oncologists to improve their assessment of performance status, especially for male patients. Female patients had lower levels of steps/hour than males and lower correlations among the predictors, suggesting the need for further work to improve performance status assessment in women. Assessment of pre-morbid sedentary behavior alongside current Physical Functioning and Fatigue PROs may allow for a more valid determination of disease-related activity level and performance status.
Introduction
In oncology, "Performance Status" (PS) is a critical metric used to determine treatment eligibility and predict clinical outcomes. For decades, the Eastern Cooperative Oncology Group (ECOG) scale has been the industry standard, where clinicians assign a score from 0 (fully active) to 5 (deceased) based on a brief office visit. However, these ratings are often subjective and may not accurately reflect a patient's daily activity in their natural environment. This pilot study investigates whether standardized Patient-Reported Outcomes (PROs) can provide a more reliable and objective assessment of physical function by comparing them to wearable actigraphy data.
Methods
The researchers conducted a single-arm observational pilot study with 65 oncology patients across four sites, including the University of Southern California and MD Anderson Cancer Center. Complete data was analyzed for 42 patients starting emetogenic chemotherapy for various solid tumors.
Physical activity was objectively measured using a Microsoft Band 2 to track steps per hour over the first 14 days of treatment. Simultaneously, patients completed PROMIS® (Patient-Reported Outcomes Measurement Information System) surveys via a smartphone app, focusing on physical function, fatigue, and sleep. Baseline ECOG ratings were provided by both oncologists and patients for comparison against the objective step counts.
Key Results
The study revealed a significant discrepancy between traditional clinician ratings and objective activity data. Clinician ECOG ratings did not significantly correlate with actual steps taken, suggesting that brief clinical consultations fail to capture the reality of a patient’s functional status outside the clinic.
In contrast, PROMIS Physical Function scores demonstrated a strong correlation with objective actigraphy ($r = 0.57$ overall). This relationship was particularly pronounced in male patients ($r = 0.75$). Fatigue scores also showed a high predictive value for activity levels in men ($r = -0.79$).
Conversely, both oncologist and patient ECOG ratings showed poor correspondence with objective physical activity, with correlations ranging from -0.08 to -0.38 and confidence intervals often including zero.
Interestingly, a "gender gap" was observed; predictors were more accurate for men than women. For female patients, neither activity metrics nor traditional ratings predicted unexpected medical events (e.g., hospitalizations), with body weight being the only significant predictor for such events in this group. The authors suggest this may be due to differences in pre-morbid activity levels or age distributions between genders in the study cohort.
Discussion and Conclusion
This pilot study demonstrates that standardized PROs, specifically PROMIS Physical Function and Fatigue, can serve as effective proxies for objective physical activity monitoring. The high compliance rate (88-90%) suggests that digital health monitoring is feasible even in diverse, low-income patient populations.
However, the study's small sample size ($N=42$) and the lack of data on pre-morbid sedentary behavior are notable limitations. Future research should focus on larger cohorts and incorporate "baseline" activity levels to better isolate the impact of cancer on performance status. Integrating PROs into routine clinical practice could lead to more personalized and accurate treatment decisions, ensuring patients receive the most appropriate care based on their true functional capacity.
Summary updated